Determination of ethane, pentane and isoprene in exhaled air--effects of breath-holding, flow rate and purified air.
OBJECTIVE
Exhaled ethane, pentane and isoprene have been proposed as biomarkers of oxidative stress. The objectives were to explore whether ethane, pentane and isoprene are produced within the airways and to explore the effect of different sampling parameters on analyte concentrations.


METHODS
The flow dependency of the analyte concentrations, the concentrations in dead-space and alveolar air after breath-holding and the influence of inhaling purified air on analyte concentrations were investigated. The analytical method involved thermal desorption from sorbent tubes and gas chromatography. The studied group comprised 13 subjects with clinically stable asthma and 14 healthy controls.


RESULTS
Ethane concentrations decreased slightly, but significantly, at higher flow rates in subjects with asthma (P = 0.0063) but not in healthy controls. Pentane levels were increased at higher flow rates both in healthy and asthmatic subjects (P = 0.022 and 0.0063 respectively). Isoprene levels were increased at higher flow rates, but only significantly in healthy subjects (P = 0.0034). After breath-holding, no significant changes in ethane levels were observed. Pentane and isoprene levels increased significantly after 20 s of breath-holding. Inhalation of purified air before exhalation resulted in a substantial decrease in ethane levels, a moderate decrease in pentane levels and an increase in isoprene levels.


CONCLUSIONS
The major fractions of exhaled ethane, pentane and isoprene seem to be of systemic origin. There was, however, a tendency for ethane to be flow rate dependent in asthmatic subjects, although to a very limited extent, suggesting that small amounts of ethane may be formed in the airways.
Lärstad
M A E
MA
Department of Occupational and Environmental Medicine, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. mona.larstad@amm.gu.se
Torén
K
K
Bake
B
B
Olin
A-C
AC
D000328:Adult; D001249:Asthma / Q000503:physiopathology*; D015415:Biomarkers / Q000032:analysis; D001944:Breath Tests / Q000379:methods*; D002070:Butadienes / Q000032:analysis*; D004980:Ethane / Q000032:analysis*; D045853:Exhalation / Q000502:physiology; D005260:Female; D045782:Hemiterpenes / Q000032:analysis*; D006801:Humans; D001239:Inhalation / Q000502:physiology; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology; D010420:Pentanes / Q000032:analysis*
D015415:Biomarkers; D002070:Butadienes; D045782:Hemiterpenes; D010420:Pentanes; C005059:isoprene; C033353:pentane; D004980:Ethane